TNFRSF1B and neoplasm: Therefore, therapeutic strategies targeting TNFR2-mediated tumor growth include depletion of TNFR2-expressing Tregs (van der Most et al., 2009) and antagonistic antibodies targeting TNFR2 over-expressed on tumor cells.